SIF Midco Limited
- Company number
- 16485966
- Status
- Active
- Type
- Private Limited Company
- Incorporated
- 30 May 2025
- Nature of business
- Activities of other holding companies n.e.c.
- Corporate group
- SIF Holdco 1 Limited (12 companies)
Registered office
Officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| DAHLE, Bendik | Director | 30 May 2025 | 13 Aug 2026 |
| COX, Stephen Robert | Director | 13 Aug 2026 | |
| CANNON, David | Director | 13 Aug 2026 |
Control
| Name | Nature of control | Notified | Ceased |
|---|---|---|---|
| The Carlyle Group Inc. | Significant Influence Or Control | 30 May 2025 | 14 Jul 2026 |
| Sif Holdco 2 Limited | Ownership Of Shares 75 To 100 Percent Voting Rights 75 To 100 Percent Right To Appoint And Remove Directors |
14 Jul 2026 |
Connections
Owned by
SIF Midco Limited → SIF Holdco 2 Limited → SIF Holdco 1 Limited
Controls
- SIF Bidco Limited (16486066)
Directors’ other companies
- CANNON, David - Director at AP Baleine 3 Holdings Limited
- CANNON, David - Director at AP Baleine 3 UK Limited
- CANNON, David - Director at SIF Bidco Limited
- CANNON, David - Director at Altera Infrastructure Production Holdings Limited
- CANNON, David - Director at SIF Holdco 2 Limited
- CANNON, David - Director at SIF Holdco 1 Limited
- COX, Stephen Robert - Director at SIF Holdco 2 Limited
- COX, Stephen Robert - Director at SIF Holdco 1 Limited
- COX, Stephen Robert - Director at Altera Infrastructure Production Holdings Limited
- COX, Stephen Robert - Director at Golar-Nor (UK) Limited
Companies at the same address
- Abingworth Avillion Blocker Limited (08298936)
- Abingworth Bioventures 8 LP (LP020555)
- Abingworth Bioventures Gp Limited (08012038)
- Abingworth Bioventures Vi LP (LP015017)
- Abingworth Bioventures Vii LP (LP017463)
- Abingworth Ccd Gp Limited (09622429)
- Abingworth Clinical Co-Development Fund 2 Co-Investment LP (LP021704)
- Abingworth Clinical Co-Development Fund 2 LP (LP021179)
- Abingworth Clinical Co-Development Fund LP (LP016687)
- Abingworth LLP (OC320188)